Home Cart Sign in  
Chemical Structure| 197250-15-0 Chemical Structure| 197250-15-0

Structure of Gap 26
CAS No.: 197250-15-0

Chemical Structure| 197250-15-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gap 26, a mimetic peptide of connexin, is the gap junction blocker that corresponds to the residues 63-75 of connexin 43.

Synonyms: Gap Junction Peptide 26; VCYDKSFPISHVR; Gap 26 (trifluoroacetate salt)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gap 26

CAS No. :197250-15-0
Formula : C70H107N19O19S
M.W : 1550.77
SMILES Code : OC(C=C1)=CC=C1C[C@H](NC([C@H](CS)NC([C@@H](N)C(C)C)=O)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CO)C(N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N[C@]([C@@H](C)CC)([H])C(N[C@@H](CO)C(N[C@H](C(N[C@@H](C(C)C)C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)CC4=CNC=N4)=O)=O)=O)=O)=O)=O)=O)=O
Synonyms :
Gap Junction Peptide 26; VCYDKSFPISHVR; Gap 26 (trifluoroacetate salt)
MDL No. :MFCD06411601
InChI Key :FDPIMWZHGJNESB-VCSXYVMHSA-N
Pubchem ID :25088334

Safety of Gap 26

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Gap 26

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
786-O cells 0.02 µg/µL and 0.04 µg/µL 12 hours To evaluate the effect of Gap 26 on the migratory capacity of 786-O cells, results showed that the GAP26-treated group had an almost 2-fold increase in the rate of scratch healing compared to the control group Medicina (Kaunas). 2024 May 8;60(5):780
astrocytes 100 μM 48 hours Gap26 inhibited intercellular dye transfer and further inhibited cellular coupling. J Neuroinflammation. 2018 Mar 27;15(1):97
Primary brain microvascular endothelial cells (pBMECs) 161 μM 30 min pretreatment +3 h post irradiation Significantly inhibited γ-H2AX counts in the bystander zone but not in the irradiated zone Cell Death Dis. 2020 Mar 18;11(3):194
RBE4 cells 161 μM 30 min pretreatment +3 h post irradiation Significantly inhibited γ-H2AX-positive cell counts in both irradiated and bystander zones Cell Death Dis. 2020 Mar 18;11(3):194
Human umbilical artery smooth muscle cells (HUASMCs) 0.25 mg/ml Inhibited Cx43-GJs function, reduced Ca2+ transfer between neighboring cells, leading to significant decreases in F-actin polymerization and MLC2 phosphorylation Cell Commun Signal. 2023 Jun 28;21(1):163
BEAS-2B cells 300 μM 1 hour Inhibited Cx43 function and attenuated LPS-induced BEAS-2B cell damage J Transl Med. 2016 Jun 30;14(1):194
white adipocytes 100 µM 30 minutes completely suppressed Ca2+ oscillations in all white adipocytes Int J Mol Sci. 2021 Jul 28;22(15):8095

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male Wistar rats Isolated perfused heart model Perfusion buffer 0.5 µM Prior to ischemia and initially during reperfusion Gap26 significantly reduced infarct size to 72.9 ±5.8% of control infarcts. However, when combined with ischemic preconditioning (IPC), the protection was lost (109.6 ±8.0%). Int J Mol Sci. 2022 Sep 5;23(17):10197
Male Wistar albino rats CCl4-induced cirrhotic cardiomyopathy model Intraperitoneal injection 1 µg/kg/day Three times a week for eight weeks To evaluate the effects of Gap 26 on cirrhotic cardiomyopathy. Results showed that Gap 26 improved myocardial responsiveness to isoproterenol, reduced QTc interval abnormalities, decreased spleen weight and oxidative stress markers MDA and ALT, and upregulated atrial Cx43 gene expression. Cureus. 2024 Apr 26;16(4):e59053

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.64mL

0.13mL

0.06mL

3.22mL

0.64mL

0.32mL

6.45mL

1.29mL

0.64mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories